Gil Milner
Directeur Financier/CFO chez ROBOGROUP T.E.K. LTD.
Postes actifs de Gil Milner
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GLOBE EXPLORATION (Y.C.D.) LIMITED PARTNERSHIP | Directeur/Membre du Conseil | 18/06/2019 | - |
| Independent Dir/Board Member | 18/06/2019 | - | |
| ROBOGROUP T.E.K. LTD. | Directeur Financier/CFO | - | - |
| Consus Ltd. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Gil Milner
Anciens postes connus de Gil Milner
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ANCHIANO THERAPEUTICS LTD. | Directeur/Membre du Conseil | 25/11/2012 | 01/07/2015 |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Directeur/Membre du Conseil | 01/11/2012 | - |
Campus Bio Management Ltd.
 Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Directeur/Membre du Conseil | - | - |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Comptroller/Controller/Auditor | 31/05/2007 | - |
| Directeur Financier/CFO | 22/03/2010 | - | |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Directeur Financier/CFO | - | - |
Formation de Gil Milner
| Bar-Ilan University | Undergraduate Degree |
Statistiques
Internationale
| Israël | 8 |
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 5 |
| Director of Finance/CFO | 3 |
| Comptroller/Controller/Auditor | 1 |
Sectorielle
| Health Technology | 4 |
| Finance | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
| GLOBE EXPLORATION (Y.C.D.) LIMITED PARTNERSHIP | Energy Minerals |
| ROBOGROUP T.E.K. LTD. | Technology Services |
| Entreprise privées | 5 |
|---|---|
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Finance |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
Campus Bio Management Ltd.
Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
| Consus Ltd. |
- Bourse
- Insiders
- Gil Milner
- Expérience